Farma - Bovan SA
Farma - Bovan reported total assets of 411,627 € at the end of the 2025 financial year (annual accounts filed with the NBB on 15 Oct 2026).
The score of Farma - Bovan shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +44 % Total assets -22 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Farma - Bovan's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 15 Oct 2026
- Year ended 31 Dec 2024filed on 29 Sep 2025
- Year ended 31 Dec 2023filed on 11 Oct 2024
- Year ended 31 Dec 2022filed on 09 Oct 2023
- Year ended 31 Dec 2021filed on 21 Dec 2022
Farma - Bovan's financial analysis
- Solvency38.9%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Farma - Bovan
Farma - Bovan's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0429.239.351
- VAT number
- BE0429239351
- Peppol
- Registered · 0208:0429239351 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 27 Jun 1986
- Registered office
- 9100 Sint-Niklaas
- Latest accounts
- 2025 · filed on 15 Oct 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Farma - Bovan (SA) has been based in Sint-Niklaas since 1986, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 18,521 € and equity of 159,962 €; its revenue is not published. Its solvency stands at 38.9%, below the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Farma - Bovan
Companies in the same business, of comparable size and area, outside its group.
- Ureel Pharmacie Retail sale of pharmaceutical products Couvin · balance sheet 406,984 €
- Apotheek Louisette Maes Retail sale of pharmaceutical products Puurs-Sint-Amands · balance sheet 410,986 €
- Pharmacam Retail sale of pharmaceutical products Kraainem · balance sheet 410,625 €
- Stevens Pharma Retail sale of pharmaceutical products Wezembeek-Oppem · balance sheet 406,503 €
- Pharmacie Engelbeen Retail sale of pharmaceutical products Evere · balance sheet 417,129 €
- Vertongen-de Munck Retail sale of pharmaceutical products Dendermonde · balance sheet 405,677 €
- Frenaver Retail sale of pharmaceutical products Heist-op-den-Berg · balance sheet 418,862 €
- Budin-Conserva Retail sale of pharmaceutical products Roeselare · balance sheet 419,437 €
Frequently asked questions about Farma - Bovan
What is the revenue of Farma - Bovan?
Farma - Bovan files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Farma - Bovan?
In Belgium, the VAT number is the company number prefixed with BE: BE0429239351 for Farma - Bovan, if the company is VAT-registered. Its company number (CBE) is 0429.239.351.
Where is the registered office of Farma - Bovan?
According to the CBE register, the registered office of Farma - Bovan is in 9100 Sint-Niklaas.
What is the equity of Farma - Bovan?
At the close of the 2025 financial year, the equity of Farma - Bovan amounts to 159,962 €, a solvency of 38.9% of total assets.
Who manages Farma - Bovan?
The register lists 1 active mandates at Farma - Bovan. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Farma - Bovan
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →